FewerJobs.
Employers

Employer profile

Revolution Medicines

194 open roles indexed with location, benefit, and apply-link signals where available.

ATS: greenhouse

Open roles

Showing the most recent indexed roles for this employer.

Search all matching jobs

  • Senior Director, Commercial Drug Product Manufacturing Operations

    Redwood City, California, United States

    unspecified $244K-$305K

    Senior Director, Commercial Drug Product Manufacturing Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Commercial Drug Product Manufacturing Operations will lead commercial drug product manufacturing and primary packaging activities within the Drug Product Development & Manufacturing organization. The role will oversee execution of commercial manufacturing operations across external manufacturing and packaging partners to support reliable commercial supply and lifecycle management. Responsibilities include commercial readiness activities, site qualification, technology transfer, process validation, PPQ execution, post-approval changes, troubleshooting, continued process verification (CPV), and operational excellence initiatives. The role will also support execution of commercial process monitoring activities to ensure sustained process performance and product quality. Responsibilities: - Lead execution of commercial manufacturing and primary packaging operations across CMOs and packaging partners. - Lead implementation of post-approval manufacturing and packaging changes. - Lead execution of continued process verification (CPV) activities across commercial manufacturing operations. - Manage monitoring and trending of critical process parameters, process

  • Senior Manager, Marketing, Lung

    Remote (United States)

    remote $150K-$189K

    Senior Manager, Marketing, Lung Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Senior Marketing Manager, you will be a key contributor to the development of compelling omnichannel campaigns that promote Revolution Medicine's values, scientific innovation, and patient centricity. You will develop and execute marketing strategies and plans to achieve brand objectives and growth targets, particularly for non-personal promotion initiatives. Identification and implementation of innovative digital promotion technologies will be essential to this role. You will also collaborate cross-functionally and support media planning, campaign measurement, campaign asset promotional review, and related expense budgets. - Engages in strategic market planning through developing and executing marketing strategies for lung cancer products and indications. - Understands customer needs and preferences to create engaging and effective marketing campaigns. - Oversees the execution of marketing campaigns across various channels, including digital, print, and field-based resources. - Tracks and analyzes marketing campaign performance to identify areas for improvement and provide recommendations for

  • Associate Director, HEOR, Japan

    Remote (Japan)

    remote Salary not disclosed

    Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and

  • Senior Manager, Medical Science Liaison, Japan

    Remote (Japan)

    remote Salary not disclosed

    Senior Manager, Medical Science Liaison, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Medical Science Liaison (MSL). Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Reporting to JP Regional Medical Science Liaison (JPR MSL), MSLs are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence

  • Associate Director, Medical Lead GI, Japan

    Remote (Japan)

    remote Salary not disclosed

    Associate Director, Medical Lead GI, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Medical Lead (ML) for Gastrointestinal and Pancreatic cancers (GI). This role will include to develop and execute strategic medical plan including evidence generation, publication, congress activities, and so on, engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and organize medical education, advisory boards, and medical activities in congresses. Reporting to the Head of Japan Medical Affairs, ML is an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. ML will serve as a key strategic person between Revolution Medicines and healthcare professionals in collaboration with MSL team. Within assigned geographic territory, ML will be

  • Safety Scientist

    Redwood City, California, United States

    unspecified $120K-$150K

    Safety Scientist Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Safety Scientist within Global Patient Safety Science is an individual contributor who provides safety science and pharmacovigilance support to all products across the RevMed portfolio, which includes early and late phase development activities. The individual will be responsible for supporting clinical studies, review of clinical trial protocols, supporting updates to IBs, ICFs, and authoring of DSURs. Additional safety related activities will involve medical review of individual case safety reports (ICSRs), safety surveillance of assigned products and active member of cross-functional teams. The Safety Scientist will develop and maintain an understanding of the safety profile of the assigned product(s). Responsibilities include: - Proactive medical safety surveillance of ongoing clinical trials for identification of safety - Conduct ongoing safety data reviews; prepare and present summaries to internal stakeholders. - Medical review of individual case safety reports and medical review of ICSRs, routine review of safety data

  • Senior Director, Clinical Data Management

    Redwood City, California, United States

    unspecified $244K-$305K

    Senior Director, Clinical Data Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director of Clinical Data Management provides high-level leadership for data management functions within clinical research, focusing on strategic development, operational execution, and regulatory compliance to ensure data integrity for clinical trials. Key responsibilities include leading and managing data management teams, establishing and enforcing data management policies and procedures, overseeing departmental budgets, collaborating with cross-functional teams and vendors, and ensuring data management processes meet regulatory standards. This role requires extensive experience in clinical data management, strong leadership and communication skills, expertise in clinical trial methodologies, and a deep understanding of regulatory requirements including submissions and data management systems. Required Skills, Experience and Education: - Define and implement the overall vision, strategy, and goals for the clinical data management department, including developing and enforcing departmental SOPs. - Lead, manage, and develop data management teams, handling resource planning, staff training, and performance reviews.

  • Scientist II, Assay Operations, Screening Platform Technologies

    Redwood City, California, United States

    unspecified $132K-$166K

    Scientist II, Assay Operations, Screening Platform Technologies Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Scientist II, Assay Operations, Screening Platform Technologies (SPT) to support and scale next-generation cellular screening capabilities for oncology drug discovery. This role will focus on assay operations, screening execution, automation enablement, and assay scale-up to support high-throughput and high-content screening campaigns across early discovery and lead optimization programs. The successful candidate will partner closely with cross-functional collaborators across Discovery Sciences, Cancer Biology, Automation, Data Science, and external partners to establish robust, scalable, and operationally efficient screening workflows. This position is ideal for a scientist with strong experience executing and operationalizing cellular assays who enjoys working at the intersection of biology, automation, and screening infrastructure. In this role, you will support the transfer, optimization, execution, and scaling of cellular assays across multiple screening platforms, helping ensure assays are automation-ready, reproducible, and fit for high-throughput applications. You will

  • Associate Scientist, Research Laboratory Operations

    Redwood City, California, United States

    unspecified $119K-$149K

    Associate Scientist, Research Laboratory Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an individual with a strong background in rodent laboratory animal research. The position will receive study designs from scientists and independently execute in vivo pharmacology studies in mice, while demonstrating excellent communication and coordination across teams. In addition, this role will support vivarium management, including management of weekend staff to ensure uninterrupted in vivo operations during weekends and holidays. - Plan, conduct, analyze, and report in vivo studies (efficacy, PK/PD). - Carry out pre-clinical model development and characterization. - Manage and supervise multiple research associates. - Conduct standard vivarium operations-managing inventory/supplies, maintain laboratory equipment, and record keeping. - Contribute to continuous improvement of current SOPS and ensure that the appropriate SOPs are followed by all Vivarium users. - Support adherence to animal welfare guidelines and regulations. - Learn and conduct other in vivo related techniques. - Train junior

  • Manager, FP&A, Europe

    Basel, Basel-Stadt, Switzerland

    unspecified Salary not disclosed

    Manager, FP&A, Europe Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Manager, FP&A Europe will support the Sr Director FP&A Europe in driving financial planning, reporting, business analytics, and operational execution across the European region as the company prepares for commercial growth. Based in Basel, Switzerland, this role will coordinate budgeting and forecasting activities, deliver financial insights, support reporting and planning tools, and help ensure efficient day-to-day finance operations across European affiliates and functions. The ideal candidate is analytical, hands-on, highly organized, and comfortable operating in a fast-paced biotech environment. Support FP&A & Financial Operations - Support annual budget, quarterly forecast, and long-range planning processes across Europe. - Coordinate planning timelines, templates, and data collection with regional stakeholders. - Assist in maintaining European management P&L structures by country, function, and product. - Prepare monthly Actuals vs. Budget / Forecast reporting and variance analyses. - Consolidate and validate financial submissions from affiliates and functions. - Support OpEx

  • Senior Specialist, Procure to Pay, Europe

    Basel, Basel-Stadt, Switzerland

    unspecified Salary not disclosed

    Senior Specialist, Procure to Pay, Europe Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines Switzerland is seeking a motivated individual with a background in the life sciences industry to play a critical role in the accounting team. Reporting to the Senior Manager, Accounts Payable Europe, this newly created role will support the daily procure to pay operations across multiple European entities while ensuring accurate processing, adherence to internal controls and compliance with US GAAP and local statutory requirements. This role ensures accurate, timely, and compliant processing of purchase orders, vendor invoices, vendor payments, employee expense reimbursements and VAT filings while driving process improvements, standardization, and strong internal controls across the region. The role is located in Basel, Switzerland. - Ensure timely and accurate processing for vendor onboarding, vendor purchase orders, invoices, employee expense reports, and payments - Review invoice coding for correct legal entity, department, account, location and tax treatment. - Coordinate or support payment

  • Senior Accountant, General Ledger, Europe

    Basel, Basel-Stadt, Switzerland

    unspecified Salary not disclosed

    Senior Accountant, General Ledger, Europe Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a motivated individual with a background in the life sciences industry to play a critical role in the accounting team. Reporting directly to the Senior Director, Accounting Europe, this newly created role will support the daily accounting operations operations across multiple European entities. This role will be responsible for maintaining accurate financial records, supporting month-end and year-end US GAAP and local GAAP close activities, preparing journal entries and reconciliations, VAT reporting, and ensuring compliance with company policies, internal controls, and applicable accounting standards. The role is located in Basel, Switzerland. - Perform day-to-day general ledger accounting activities for European entities. - Prepare journal entries such as cash, prepayments, accruals, fixed assets, leases and other month-end close adjustments. - Support monthly, quarterly, and annual close processes in accordance with company timelines. - Prepare balance sheet reconciliations and investigate variances in a timely

  • Senior Program Manager

    Redwood City, California, United States

    unspecified $164K-$205K

    Senior Program Manager Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This is an exciting opportunity to advance first-in-Class RAS(ON) Inhibitors through clinical development. The ideal candidate is a strategic program management professional with deep experience leading cross-functional Companion Diagnostics (CDx) development activities supporting targeted oncology therapies. This individual will drive alignment across internal functions and external diagnostic partners to enable successful clinical development, regulatory execution, and commercialization readiness. The successful candidate will draw on their experience to: - Lead cross-functional Companion Diagnostics development programs supporting clinical-stage oncology assets from assay strategy through clinical and regulatory execution. - Work closely with CDx Leads and other clinical development team members to facilitate science-based CDx decision making and drive the execution of the CDx development strategy. - Develop and maintain integrated cross-functional program plans, timelines, milestones, dependencies, and critical path analyses across internal teams and external diagnostic partners. - Drive cross-functional alignment and coordinate CDx operational activities

  • Senior Manager, GMP Quality

    Redwood City, California, United States

    unspecified $164K-$205K

    Senior Manager, GMP Quality Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Senior Manager, GMP Quality who will play a key role within Quality Assurance and is responsible for providing leadership and operational support for RevMed commercial programs, with a primary focus on commercial finished product batch review, disposition, and release activities in support of global product supply. Responsibilities: - Serve as the QA lead for commercial finished product (FP) batch review and disposition activities, ensuring timely and compliant release of commercial product for distribution. - Perform comprehensive review and approval of executed batch records, deviations, investigations, analytical data, Certificates of Analysis (CoAs), and associated release documentation for commercial product disposition. - Provide QA oversight for commercial manufacturing, packaging, labeling, testing, storage, and release operations performed at CMOs, contract laboratories, and distribution partners. - Collaborate cross-functionally with Pharmaceutical Development & Manufacturing (PDM/CMC), Supply Chain, Regulatory Affairs, Technical Operations, Validation, and

  • Executive Director, Healthcare Law and Market Access

    Redwood City, California, United States

    unspecified $311K-$357K

    Executive Director, Healthcare Law and Market Access Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an Executive Director, Healthcare Law and Market Access reporting to the Vice President, Healthcare Law to join our RevMed team. The Executive Director, Healthcare Law and Market Access will serve as the zoldonrasib Legal brand lead and provide strategic legal guidance related to the company's planned zoldonrasib commercialization activities, patient access programs, distribution and licensing, and regulatory submissions. In addition, the position will serve as the senior enterprise legal leader responsible for shaping and advancing Revolution Medicines' U.S. Market Access legal strategy in support of commercialization, patient access, pricing, reimbursement, and corporate growth objectives. At a tactical level, the position will be responsible for managing all aspects of Market Access contracting through product distribution channels, including distributors, specialty distributors, specialty pharmacies, 3 rd party logistics providers and payers, and government pricing and reimbursement. A successful candidate will

  • Director, Global Patient Safety Operations

    Redwood City, California, United States

    unspecified $211K-$264K

    Director, Global Patient Safety Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly skilled and experienced Director of Global Patient Safety Operations to join our team. Reporting to the Head of Global Patient Safety Operations, this role provides leadership and oversight of safety operations, including management of pharmacovigilance vendors and serving as an internal subject matter expert. The Director will mentor and develop direct reports, execute the department's vision and strategy, and work collaboratively with cross-functional teams. In addition, the Director will collaborate cross-functionally to continuously develop and maintain the pharmacovigilance system to support Revolution Medicines' research, development, and marketed products. - Lead and manage direct reports of the Global Patient Safety Operations team - Oversee procedures related to Individual Case Safety Report processing, oversight of metrics, and compliance with global safety reporting requirements. - Oversee pharmacovigilance vendors and CROs, ensuring quality, budget, and timely delivery of safety operations activities.

  • Associate Director, Business Operations

    Redwood City, California, United States

    unspecified $186K-$233K

    Associate Director, Business Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Business Operations is an internal project manager with a consultant mindset and hands-on approach. This is an execution-focused role that strengthens the business capabilities in the Development & Clinical Sciences (DCS) organization. This role partners closely with the Development Leadership Team and the Program Leads to design and implement capabilities building projects that enable growth and evolve our ways of working. The role is ideal for a Associate Director -level professional who thrives on execution, can drive several projects in parallel, can navigate a matrix environment, and brings strong project leadership, communication and change management experience. Responsibilities: - Enablement Programs & Tools - Design and deploy practical solutions (e.g., templates, toolkits, playbooks, workflows) that enable DCS teams in their day-to-day work. - Ensure solutions are practical, scalable, and embedded into existing processes. - Partner with subject-matter experts to translate complex

  • Senior Research Associate, Proteomics

    Redwood City, California, United States

    unspecified $106K-$126K

    Senior Research Associate, Proteomics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated and detail-oriented individual to support and advance mass spectrometry-based proteomics workflows. This role is well-suited for a scientist with prior industry experience who is excited to apply and expand their expertise in proteomics within a drug discovery environment. This position will involve executing and optimizing laboratory workflows, maintaining high-quality data standards, and contributing to the development of new capabilities within the team. The ideal candidate will demonstrate strong technical proficiency, attention to detail, and the ability to work both independently and collaboratively. In this role, success will come from consistently delivering high-quality, reproducible data, maintaining well-documented experiments, and proactively identifying opportunities to improve workflows and efficiency. As a key member of the Proteomics group within our dynamic Chemical Biology team, you will: - Perform sample preparation for bottom-up proteomics workflows with high attention to detail and reproducibility.

  • Research Associate II, Proteomics

    Redwood City, California, United States

    unspecified $91K-$110K

    Research Associate II, Proteomics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated and detail-oriented individual to support mass spectrometry-based proteomics workflows. This is an excellent opportunity for an early-career scientist to gain hands-on experience in proteomics within a drug discovery environment. This role will focus on executing established laboratory workflows, maintaining high-quality data standards, and supporting the development of new capabilities within the team. Training will be provided for specialized techniques and instrumentation. In this role, success will come from consistently executing workflows with accuracy, maintaining well-documented experiments, and building technical proficiency over time. As a key member of the Proteomics group within our dynamic Chemical Biology team, you will: - Perform sample preparation for bottom-up proteomics workflows using established protocols with high attention to detail and consistency. - Execute and help improve automated proteomics workflows. - Support routine instrument operation, maintenance and quality control of LC and MS/MS

  • Associate Director, Learning & Engagement

    Redwood City, California, United States

    unspecified $186K-$233K

    Associate Director, Learning & Engagement Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This is an exciting opportunity to lead the Learning & Engagement initiatives. The Associate Director, Learning & Engagement will lead the design, development and implementation of learning initiatives, instructional design solutions, learning forums, and infrastructure initiatives across partnered functions and in close alignment with HR and RevMed Learning and Engagement functions' best practices. This role requires a blend of Learning & Development expertise, a solid understanding of drug development processes & skillsets, and the communication abilities to support a diverse portfolio of strategic growth initiatives. Responsibilities: - Lead and deliver innovative learning programs that support the implementation and continuous improvement of DCS Growth & Enablement strategic roadmap and initiatives. - Drive the adoption of new business processes through training, communication, knowledge management, and change management. - Collaborate within Business Operations and across department leaders and functional subject-matter experts to assess training needs,